Transbronchial needle aspiration: where are we now?

J Thorac Dis

Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; ; Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Published: October 2013

Lung cancer, as the leading cause of cancer-related motility and mortality worldwide, usually ends up with poor prognosis, despite abundant progress of therapeutic approaches. Early diagnosis and staging is extremely critical and directly affects clinical managements and outcomes. Transbronchial needle aspiration (TBNA), serving as an effective tool, has been widely used for mediastinal and hilar lung cancer staging. Recent advance in bronchoscopy introduces ultrasound probe to regular bronchoscope, resulting in TBNA procedures real-time visualized. Here, we summarize the advantages and disadvantages of conventional TBNA (cTBNA) and ultrasound-guided TBNA by comparing the instruments, methodology as well as the anatomy. We believe these two techniques are not competitive but complementary, judging the indications of patients for different technique would be a raising issue applied for pulmonologists.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815731PMC
http://dx.doi.org/10.3978/j.issn.2072-1439.2013.09.11DOI Listing

Publication Analysis

Top Keywords

transbronchial needle
8
needle aspiration
8
lung cancer
8
aspiration now?
4
now? lung
4
cancer leading
4
leading cancer-related
4
cancer-related motility
4
motility mortality
4
mortality worldwide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!